India's Production Linked Incentive (PLI) program has prompted significant investments in the pharmaceutical industry with the intention of strengthening domestic manufacturing and decreasing import dependence, as per the data from the Department...
The approach of precision medicine is designed for healthcare customization, with treatments being specifically designed to match the distinct genetic makeup, habits, and environmental exposures of each patient
The Indian pharmaceutical industry is currently investing a lot into innovation in order to keep up with the global competition. Many companies are focusing on development of novel drug delivery systems.
Halozyme Therapeutics, Inc, a biopharmaceutical firm, recently made the announcement that it had been granted European Patent No. 4269578. This patent covers the Enhanze rHuPH20 product that is made using Halozyme's Enhanze manufacturing methods...
Biotech driven drug discovery continues to be one of the fastest growing markets globally. The advancement in technology has enabled researchers to accelerate the time to market, while continuing to optimize the costs.
Aurigene Pharmaceutical Services Limited (“Aurigeneâ€), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft.in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed...
Eli Lilly, a pharmaceutical company, has declared it is funding one more $5.3 billion in an manufacturing plant in Lebanon, Indiana, to support the assembling of its exceptionally famous weight reduction drug Zepbound, diabetes treatment Mounjaro...
Emcure Pharmaceuticals Ltd. and its biotech subsidiary, Gennova Biopharmaceuticals Ltd. have amicably resolved all legal disputes with HDT Bio Corp. The litigation between them, including before US courts and the arbitral tribunal in London, has...
Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceuticals company, proudly announced the launch of the next phase of ‘India First Heart First’ campaign.
.jpg)
The biggest challenge in drug discovery today is the time taken. The number of new drugs entering the market compared to the number of drugs required is very less. Moreover, for the phase 2 clinical trials, the failure rate is over 90% percent which
, CDSCO.jpg)
